Amidst a raging global controversy, hydroxychloroquine (HCQ) makers in India continue to produce the drug for regular rheumatoid arthritis and diabetes patients apart from catering to export orders. India is the world's largest manufacturer of HCQ, which is also an anti-malaria drug.
The once touted “wonder drug” has been battling global controversies around its safety and efficacy as a prophylactic against Covid-19. India continues to use the drug as a preventive for frontline workers like health care professionals and police personnel, apart from high-risk individuals, like close contacts of Covid-19 patients.
A source in one of India’s leading HCQ manufacturing